UASt regulatory sequences drive expression of an inverted repeat.
Expression of ebiGD1329 under the control of Scer\GAL4bbg-C96 results in notching along the adult wing margin and a reduction in wing size, as compared to controls.
Adults expressing ebiGD1329 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression under the control of Scer\GAL4Mef2.PR results in early pupal lethality.
Expression under the control of Scer\GAL4pnr-MD237 results in lethality or semi-lethality at the pupal stage, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 10-20% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 90-100% of the Scer\GAL4pnr-MD237-expressing area of the notum.
Expression of ebiGD1329 under the control of Scer\GAL4Bx-MS1096 leads to crinkled and necrotic wings.
Expression of ebiGD1329 under the control of Scer\GAL4ey.PH and Scer\GAL4GMR.PF leads to a rough eye phenotype.
Expression of ebiGD1329 under the control of Scer\GAL4pnr-MD237 results in a mild defective thorax closure phenotype.
Scer\GAL4GMR.PF, Scer\GAL4ey.PH, ebiGD1329 has lethal | female phenotype, enhanceable by Dcr-2UAS.cDa, Scer\GAL4GMR.PF, Scer\GAL4ey.PH
Scer\GAL4pnr-MD237, ebiGD1329 has thorax phenotype, enhanceable by Dcr-2UAS.cDa, Scer\GAL4pnr-MD237
Coexpression of Dcr-2Scer\UAS.cDa with ebiGD1329, under the control of Scer\GAL4pnr-MD237, leads to an enhancement of the defective thorax closure phenotype seen when only ebiGD1329 is expressed.